Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study

1995 ◽  
Vol 10 (1) ◽  
pp. 40-43 ◽  
Author(s):  
J. Dor ◽  
D.S. Seidman ◽  
E. Amudai ◽  
D. Bider ◽  
D. Levran ◽  
...  
Keyword(s):  
Growth Hormone ◽  
In Vitro Fertilization ◽  
Hormone Therapy ◽  
Growth Hormone Therapy ◽  
Blind Study ◽  
Poor Responders ◽  
Double Blind Study ◽  
Double Blind ◽  
Vitro Fertilization

The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study*

1992 ◽  
Vol 58 (3) ◽  
pp. 575-580 ◽  
Author(s):  
Johnny S. Younis ◽  
Alexander Simon ◽  
Ronit Koren ◽  
Daniel Dorembus ◽  
Joseph G. Schenker ◽  
...  
Keyword(s):  
Growth Hormone ◽  
In Vitro Fertilization ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Vitro Fertilization

Is analgesia required for transvaginal single-follicle aspiration in in vitro fertilization? A double-blind study

1990 ◽  
Vol 7 (2) ◽  
pp. 103-106 ◽  
Author(s):  
Samuel S. Ramsewak ◽  
Anju Kumar ◽  
Rosalie Welsby ◽  
Anne Mowforth ◽  
Elizabeth A. Lenton ◽  
...  
Keyword(s):  
In Vitro Fertilization ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind ◽  
Vitro Fertilization ◽  
Follicle Aspiration

The Effect of Atosiban on Patients With Difficult Embryo Transfers Undergoing In Vitro Fertilization–Embryo Transfer

2019 ◽  
Vol 26 (12) ◽  
pp. 1613-1617 ◽  
Author(s):  
Caixia Yuan ◽  
Haixia Song ◽  
Lingling Fan ◽  
Shili Su ◽  
Baihua Dong
Keyword(s):  
In Vitro Fertilization ◽  
Implantation Rate ◽  
Clinical Pregnancy ◽  
Double Blind Study ◽  
Double Blind ◽  
Vitro Fertilization ◽  
Infertile Women ◽  
Cryopreserved Embryos ◽  
Ivf Et

The purpose of this study was to evaluate the effect of atosiban on the outcomes of infertile women undergoing in vitro fertilization (IVF) with difficult embryo transfers (ETs). This randomized double-blind study enrolled 204 infertile women with difficult ETs during IVF treatment between June 2014 and June 2018. According to a computer-generated randomization list, participants were randomized into placebo (n = 102) and atosiban (n = 102) groups. In atosiban group, atosiban with a total dose of 37.5 mg was administered. All of the patients underwent IVF-ET using cryopreserved embryos. The clinical pregnancy rate per cycle and implantation rate per transfer (45.1% and 26.5%) in atosiban group were significantly higher than those of placebo group (15.6% and 9.7%, respectively; P < .05). This study showed that administration of atosiban during ET was extraordinarily effective for patients with difficult transfers.

Sign in / Sign up

Export Citation Format

Share Document